A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

February 2, 2021

Study Completion Date

February 2, 2021

Conditions
Non Small Cell Lung CancerCancer
Interventions
DRUG

Venetoclax

Tablet: Oral

DRUG

Pembrolizumab

Intravenous (IV) Infusion

Trial Locations (39)

10065

Weill Cornell Medical Center /ID# 216911, New York

15212

Allegheny General Hospital /ID# 214363, Pittsburgh

22031

Virginia Cancer Specialists /ID# 214328, Fairfax

23298

Massey Cancer Centre /ID# 212527, Richmond

30912

Georgia Regents University /ID# 217109, Augusta

32804

AdventHealth Cancer Institute - Orlando /ID# 214444, Orlando

35233

Univ of Alabama at Birmingham /ID# 214180, Birmingham

37916

Thompson Cancer Survival Ctr /ID# 217076, Knoxville

40202

University of Louisville /ID# 215195, Louisville

41101

Ashland-Bellefonte Cancer Ctr /ID# 218511, Ashland

44106

University Hospitals Cleveland /ID# 212241, Cleveland

46804

Fort Wayne Medical Oncology /ID# 214954, Fort Wayne

48201

Karmanos Cancer Institute /ID# 216986, Detroit

48202

Henry Ford Health System /ID# 216385, Detroit

60426

Ingalls Memorial Hosp /ID# 214952, Harvey

60612

Rush University Medical Center /ID# 212448, Chicago

63110

Washington University-School of Medicine /ID# 212355, St Louis

77030

Houston Methodist Hospital - Scurlock Tower /ID# 215481, Houston

84106

Utah Cancer Specialists /ID# 215496, Salt Lake City

85704

Arizona Oncology Associates, PC-HOPE (Rudasill) /ID# 216984, Tucson

90603

Icri /Id# 217071, Whittier

95403

St Jude Hospital dba St Joseph /ID# 212360, Santa Rosa

97225

Providence Cancer Center Oncology and Hematology Care - Westside Portland /ID# 215497, Portland

98405

Multicare Institute for Research and Innovation /ID# 217913, Tacoma

Northwest Medical Specialties /ID# 218484, Tacoma

60637-1443

University of Chicago DCAM /ID# 214319, Chicago

04240

Central Maine Medical Center /ID# 216107, Lewiston

21044-3128

Maryland Oncology Hematology /ID# 214131, Columbia

01655

University of Massachusetts Ca /ID# 218744, Worcester

39216-4500

Univ of Mississippi Med Ctr /ID# 216429, Jackson

68114-4108

Methodist Estabrook Cancer Center /ID# 216910, Omaha

68198-6840

University of Nebraska Medical Center /ID# 216754, Omaha

07601

Hackensack Univ Med Ctr /ID# 216484, Hackensack

07960-6136

Atlantic Health System /ID# 217067, Morristown

07901-3533

Overlook Medical Center /ID# 219108, Summit

10016-4744

NYU Langone - Laura and Isaac Perlmutter Cancer Center /ID# 218077, New York

45219-2364

University of Cincinnati Cancer Institute /ID# 216800, Cincinnati

43210-1240

The Ohio State University - The James /ID# 212298, Columbus

29605-4255

Prisma Health Cancer Institute - Faris /ID# 217946, Greenville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY